Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 GNC Makes NYSE Debut - Nutraceuticals World
Market Updates

GNC Makes NYSE Debut

Following through with its initial public offering (IPO), shares of GNC Holdings, Inc., Pittsburgh, PA, rose April 1 after debuting as a publicly traded company on the New York Stock Exchange (NYSE). That day, according to Reuters: “GNC shares gained 4.7%, finishing their first day of trading on NYSE at $16.75 after pricing at $16 in the company’s third attempt at a public offering.” The Pittsburgh Post-Gazette reported the IPO was valued at $360 million as the company issued and sold 16 million shares, while selling stockholders sold 6.5 million. “For its part, GNC plans to use its net proceeds of about $240 million, in addition to cash on hand, to pay down debt among other things,” the Post-Gazette said. Goldman, Sachs & Co. and J.P. Morgan Securities LLC, along with Deutsche Bank Securities Inc. and Morgan Stanley & Co. Incorporated, acted as joint bookrunners for the offering, and Barclays Capital Inc., Credit Suisse Securities (USA) LLC, William Blair & Company, L.L.C. and BMO Capital Markets Corp. acted as co-managers. GNC has more than 7200 locations, of which more than 5600 retail locations are in the U.S.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters